Erlotinib and interstitial lung disease Patient Reports February 11, 2012

Erlotinib Side Effects Report #5477800-2
Erlotinib side effect was reported by a Physician from BELGIUM on Sept 17, 2007. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: deep vein thrombosis

, haemoglobin decreased, interstitial lung disease, respiratory failure, somnolence. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, CAPOTEN, HYDROCODONE BITARTRATE, OMEPRAZOLE, PANCREATIN TRIPLE STRENGTH CAP, LYSOMUCIL, LANTUS. Patient was hospitalized. Patient died on 02/06/2006.

Erlotinib Side Effects Report #6121207-1
Erlotinib side effect was reported by a Physician from ITALY on Feb 27, 2009. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, interstitial lung disease, lung disorder, lymphangitis, pneumocystis jiroveci infection, pneumonia

. Erlotinib dosage: (100 MG, QD), ORAL. Patient died.

Erlotinib Side Effects Report #5808286-3
Erlotinib side effect was reported by a Physician from UNITED STATES on June 24, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, dehydration, discomfort, dysphagia, failure to thrive, interstitial lung disease, pain

, pancytopenia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5171408-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 08, 2006. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, metastasis, respiratory failure. Erlotinib dosage: 150 MG DAILY PO. During the same period patient was treated with ATORVASTATIN, ZETIA, NEXIUM, ACCUPRIL, TOPROL, TIMOPTIC, XALATAN, VICODIN. Patient died on 11/27/2006.

Erlotinib Side Effects Report #6132617-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood glucose decreased, gastric ulcer, haematemesis, interstitial lung disease, loss of consciousness, metastases to bone, metastases to lung, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BASEN, AMARYL, PURSENNID, MAGMITT, OXYCONTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5716934-1
Erlotinib side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Apr 10, 2008. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, neutrophil count increased, pneumonia bacterial, respiratory failure. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CEFTIZOXIME, CLINDAMYCIN. Patient was hospitalized. Patient died on 01/20/2008.

Erlotinib Side Effects Report #5757734-6
Erlotinib side effect was reported by a Health Professional from JAPAN on May 27, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation

, ejection fraction decreased, interstitial lung disease, shock. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with FLORID, PRIMEPERAN, LANIRAPID, FAMOTIDINE, WARFARIN, ABILIT, AMOBAN, DESRYL. Patient died on 05/05/2008.

Erlotinib Side Effects Report #6058145-9
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Jan 13, 2009. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease. Erlotinib dosage: (150 MG, QD), ORAL. Patient died on 05/19/2008.

Erlotinib Side Effects Report #5736884-4
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 24, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: autoimmune thrombocytopenia, blood lactate dehydrogenase increased, disease progression, interstitial lung disease, skin disorder. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RISEDRONIC ACID, MUCOSTA, TRANSAMIN. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5776183-8
Erlotinib side effect was reported by a Physician from JAPAN on May 29, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, interstitial lung disease, metastases to bone, metastases to central nervous system, performance status decreased, skin disorder. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RISEDRONIC ACID, MUCOSTA, TRANSAMIN. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #6073069-9
Erlotinib side effect was reported by a Physician from SPAIN on Jan 05, 2009. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchospasm, hyperglycaemia, interstitial lung disease, oral herpes, radiation pneumonitis, staphylococcal infection

. Erlotinib dosage: (150 MG,QD),ORAL ; (150 MG,QD),ORAL. During the same period patient was treated with PREDNISONA, SALBUTAMOL, OMEPRAZOLE, IPATROPIO BROMURO, FLUTICASONA, NOVOMIX, SERETIDE. Patient was hospitalized. Patient died on 07/22/2008.

Erlotinib Side Effects Report #5869361-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 08, 2008. Male patient, 70 years of age, weighting 120.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac tamponade, hepatic function abnormal, interstitial lung disease, rash

. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with TAZOCIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5500155-1
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Oct 10, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood calcium decreased, blood glucose increased, blood phosphorus decreased, blood sodium decreased, carbon dioxide decreased, disease progression, interstitial lung disease, lymphocyte percentage decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL. Patient died on 07/17/2007.

Erlotinib Side Effects Report #5578137-3
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Dec 17, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood calcium decreased, blood glucose increased, blood phosphorus decreased, blood sodium decreased, carbon dioxide decreased, interstitial lung disease, lymphocyte percentage decreased, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL. Patient died on 07/17/2007.

Erlotinib Side Effects Report #5229275-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2007. Male patient, 65 years of age, weighting 197.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphadenopathy, pneumonia

, pulmonary oedema, respiratory failure. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, OXYGEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5988410-2
Erlotinib side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient, 61 years of age, weighting 129.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hyponatraemia, interstitial lung disease. Erlotinib dosage: 150 MG, QD), ORAL. During the same period patient was treated with PURSENNID, LENDORM, ZOLPIDEM TARTRATE, TRAMAZOLINE HYDROCHLORIDE, NAIXAN. Patient recovered.

Erlotinib Side Effects Report #6106824-7
Erlotinib side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 61 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematuria, interstitial lung disease, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL, (100 MG, QD), ORAL. During the same period patient was treated with LOPERAMIDE, GARENOXACIN MESILATE. Patient recovered.

Erlotinib Side Effects Report #5818452-9
Erlotinib side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase decreased, interstitial lung disease, laboratory test abnormal, rash

. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MAXIPIME, CIPROFLOXACIN, MEROPEN, MUCODYNE, MAGLAX, NOVAMIN, NAIXAN, OXYCONTIN. Patient was hospitalized. Patient died on 04/30/2008.

Erlotinib Side Effects Report #5832480-9
Erlotinib side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase decreased, bronchostenosis, c-reactive protein increased, hepatic function abnormal, interstitial lung disease, malignant neoplasm progression. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MAXIPIME, CIPROFLOXACIN, MEROPEN, MUCODYNE, MAGLAX, NOVAMIN, NAIXAN, OXYCONTIN. Patient was hospitalized. Patient died on 04/30/2008.

Erlotinib Side Effects Report #6025084-9
Erlotinib side effect was reported by a Physician from JAPAN on Dec 17, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, disease progression, interstitial lung disease, mediastinal disorder, metastases to bone, metastases to lung, metastases to lymph nodes, non-small cell lung cancer stage iv, rash

. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with MAXIPIME, CIPROFLOXACIN, MEROPEN, MUCODYNE, MAGLAX, NOVAMIN, NAIXAN. Patient was hospitalized. Patient died on 04/30/2008.

Erlotinib Side Effects Report #4679762-4
Erlotinib side effect was reported by a Physician from on Mar 18, 2005. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature decreased, dyspnoea exertional, haemoptysis, interstitial lung disease, respiratory disorder, stomatitis. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TRIAMCINOLONE ACETONIDE. Patient was hospitalized. Patient died on 05/11/2005.

Erlotinib Side Effects Report #5822140-2
Erlotinib side effect was reported by a Physician from GERMANY on July 09, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, interstitial lung disease, lymphocyte percentage decreased, pneumonia

. Erlotinib dosage: unknown. During the same period patient was treated with FLUORODEOXYGLUCOSE F, FLUOROTHYMIDINE F, NOVAMINSULFON, BELOC, NEXIUM, NOVALGIN, ZOMETA. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5633822-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Feb 08, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hyperkalaemia, hypernatraemia, interstitial lung disease, lower respiratory tract infection bacterial, no therapeutic response, platelet count decreased, pulmonary tuberculosis, respiratory failure. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with RIZE, CLONAZEPAM, METHYLCOBAL, LOXONIN, PRIMPERAN, AMITRIPTYLINE, PURSENNID, DUROTEP. Patient died.

Erlotinib Side Effects Report #5798556-X
Erlotinib side effect was reported by a Physician from JAPAN on June 13, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, depressed level of consciousness, hyperkalaemia, hypernatraemia, interstitial lung disease, platelet count decreased, pleural effusion, pneumocystis jiroveci pneumonia, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with RIZE, CLONAZEPAM, METHYCOBAL, LOXONIN, PRIMPERAN, AMITRIPTYLINE, PURSENNID, FENTANYL TRANSDERMAL SYSTEM. Patient died.

Erlotinib Side Effects Report #5381818-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 18, 2007. Female patient, 42 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, oesophagitis, pneumonitis. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5832820-0
Erlotinib side effect was reported by a Physician from JAPAN on July 17, 2008. Male patient, 89 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pneumonia

. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with NAUZELIN, MEDICON, SELBEX, OMEPRAZOLE. Patient died.

Erlotinib Side Effects Report #5878590-1
Erlotinib side effect was reported by a Physician from JAPAN on Aug 25, 2008. Male patient, 89 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, non-small cell lung cancer, respiratory failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with NAUZELIN, MEDICON, SELBEX, OMEPRAZOLE, LOXONIN. Patient died.

Erlotinib Side Effects Report #5822588-6
Erlotinib side effect was reported by a Physician from JAPAN on July 11, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, interstitial lung disease, pyrexia, rash

. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5897654-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 08, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, interstitial lung disease, pyrexia, rash

. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient died on 07/05/2008.

Erlotinib Side Effects Report #5936268-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Oct 13, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, fall

, interstitial lung disease. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient died on 07/05/2008.

Erlotinib Side Effects Report #5981418-2
Erlotinib side effect was reported by a Health Professional from JAPAN on Nov 12, 2008. Male patient, 77 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with MAGNESIUM OXIDE, NOVAMIN, MUCOSTA, LOXOPROFEN, FERROMIA, PARIET, PREDNISOLONE, GLYCEROL. Patient died on 10/25/2008.

Erlotinib Side Effects Report #5731802-7
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 22, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, interstitial lung disease, pulmonary alveolar haemorrhage, pyrexia. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LANIRAPID, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5900766-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 11, 2008. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacteria sputum identified, catheter related infection, decubitus ulcer, folliculitis, haemophilus infection, interstitial lung disease, metastases to pleura, periproctitis, pneumonia

. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SUCRALFATE, OXYCONTIN, JUZENTAIHOTO, AMITRIPTYLINE, WARFARIN POTASSIUM, ETODOLAC, MUCOSTA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5935294-4
Erlotinib side effect was reported by a Physician from JAPAN on Oct 14, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, aspiration, interstitial lung disease, pulmonary alveolar haemorrhage, tumour haemorrhage. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LANIRAPID, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5771624-4
Erlotinib side effect was reported by a Physician from JAPAN on May 27, 2008. Male patient, 74 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BISOPROLOL FUMARATE, AMLODIPINE, CANDESARTAN CILEXETIL, MAGNESIUM OXIDE, FLUNITRAZEPAM, HANGE, NAFTOPIDIL, EVIPROSTAT. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5869423-8
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 14, 2008. Male patient, 74 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, shock. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with FLORID, PRIMEPERAN, LANIRAPID, FAMOTIDINE, WARFARIN, ABILIT, AMOBAN, DESRYL. Patient died on 05/05/2008.

Erlotinib Side Effects Report #5856871-5
Erlotinib side effect was reported by a Physician from JAPAN on Aug 07, 2008. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6094377-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Feb 10, 2009. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiomegaly, infection

, interstitial lung disease, left ventricular dysfunction, malignant neoplasm progression, pericardial effusion, pleural effusion, pneumonia viral, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, MICARDIS, HARNAL, BASEN, GLUFAST, NOVOLIN N, GASMOTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6108683-5
Erlotinib side effect was reported by a Physician from JAPAN on Feb 19, 2009. Female patient, 66 years of age, weighting 104.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastrointestinal perforation, haemophilus infection, interstitial lung disease, multi-organ failure, pneumothorax, sputum culture positive, staphylococcal infection

, stomatitis. Erlotinib dosage: (150 MG, QD), ORAL : (100 MG, QD), ORAL. During the same period patient was treated with LOXONIN, GAMOFA, MAGMITT, MUCOSTA, OXYCONTIN, PAXIL, HALCION. Patient died on 07/27/2008.

Erlotinib Side Effects Report #5935299-3
Erlotinib side effect was reported by a Physician from JAPAN on Oct 13, 2008. Male patient, 62 years of age, weighting 138.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, depression

, diarrhoea, disease progression, hepatic function abnormal, interstitial lung disease, lung adenocarcinoma, rash

, restlessness. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MYSLEE, DEPAKENE, GASMOTIN, METHYCOBAL, CYTOTEC, OXYCONTIN, NAIXAN, GASTROM. Patient died.

Erlotinib Side Effects Report #6025539-7
Erlotinib side effect was reported by a Physician from JAPAN on Dec 15, 2008. Male patient, 62 years of age, weighting 138.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, depression

, diarrhoea, hepatic function abnormal, interstitial lung disease, lung adenocarcinoma, malignant neoplasm progression, rash

, restlessness. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with MYSLEE, DEPAKENE, GASMOTIN, METHYCOBAL, CYTOTEC, OXYCONTIN, NAIXAN, GASTROM. Patient died on 07/02/2008.

Erlotinib Side Effects Report #5744902-2
Erlotinib side effect was reported by a Health Professional from JAPAN on May 02, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation

, disease progression, interstitial lung disease, pulmonary alveolar haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with OXYCONTIN, MOHRUS, LOXONIN, ZANTAC, ADALAT, MYONAL, MUCOSTA, THIATON. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5776184-X
Erlotinib side effect was reported by a Physician from JAPAN on May 29, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, interstitial lung disease. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with OXYCONTIN, MOHRUS, LOXONIN, ZANTAC, ADALAT, MYONAL, MUCOSTA, THIATON. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5691936-2
Erlotinib side effect was reported by a Physician from JAPAN on Feb 15, 2008. Female patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arterial disorder, dyspnoea, hypoxia, interstitial lung disease, nail disorder, no therapeutic response, palpatory finding abnormal, pleural effusion, pulmonary hypertension

. Erlotinib dosage: (150 MG,QD),ORAL. Patient died on 01/24/2008.

Erlotinib Side Effects Report #5732113-6
Erlotinib side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, hepatic function abnormal, immobile, interstitial lung disease, nail disorder, no therapeutic response, pulmonary embolism

, pulmonary hypertension

, pulse absent. Erlotinib dosage: (150 MG QD), ORAL. During the same period patient was treated with PREDNISOLONE, NIFEDIPINE, LOSARTAN POTASSIUM, FENOFIBRATE, DEPAS, RABEPRAZOLE, GASMOTIN, BASEN. Patient died on 01/23/2008.

Erlotinib Side Effects Report #5776186-3
Erlotinib side effect was reported by a Physician from JAPAN on May 29, 2008. Female patient, 42 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DEPAKENE, BETAMETHASONE. Patient recovered.

Erlotinib Side Effects Report #5794863-5
Erlotinib side effect was reported by a Health Professional from JAPAN on June 11, 2008. Female patient, 42 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, hypoxia, interstitial lung disease, rash

. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DEPAKENE, BETAMETHASONE. Patient died.

Erlotinib Side Effects Report #6024144-6
Erlotinib side effect was reported by a Physician from JAPAN on Dec 19, 2008. Male patient, 73 years of age, weighting 134.9 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, disease progression, disseminated intravascular coagulation, interstitial lung disease, moraxella infection, pseudomonas infection. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with TAXOTERE, AMLODIPINE, CANDESARTAN CILEXETIL, LOXOPROFEN, MUCOSTA, LENDORMTN, CODEINE PHOSPHATE. Patient recovered.

Erlotinib Side Effects Report #6060243-0
Erlotinib side effect was reported by a Physician from JAPAN on Jan 14, 2009. Male patient, 73 years of age, weighting 134.9 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, disseminated intravascular coagulation, hemiplegia, interstitial lung disease, lung disorder, pleural effusion, pseudomonas infection, sputum culture positive. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with AMLODIPINE, CANDESARTAN CILEXETIL, LOXOPROFEN, MUCOSTA, LENDORM, CODEINE PHOSPHATE. Patient was hospitalized. Patient died on 12/25/2008.

Erlotinib Side Effects Report #5844637-1
Erlotinib side effect was reported by a Physician from JAPAN on Aug 01, 2008. Male patient, 69 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, metastases to spine, respiratory failure. Erlotinib dosage: 150 MG, QD, ORAL. Patient died on 04/16/2008.

Erlotinib Side Effects Report #5936271-X
Erlotinib side effect was reported by a Physician from JAPAN on Oct 15, 2008. Male patient, 69 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphangioma, respiratory failure, tumour marker increased. Erlotinib dosage: (150 MG, QD), ORAL. Patient died on 04/16/2008.

Erlotinib Side Effects Report #5844626-7
Erlotinib side effect was reported by a Physician from JAPAN on July 31, 2008. Male patient, 66 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, bacterial infection

, c-reactive protein increased, disease progression, dyspnoea, interstitial lung disease, liver disorder, malignant pleural effusion. Erlotinib dosage: (150 MG, QD) , ORAL. During the same period patient was treated with OXYCONTIN, NOVAMIN, OXINORM, ADONA, TRANSAMIN, LASIX, PURSENNID, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Erlotinib and interstitial lung disease

SideEffects101.com

Erlotinib and interstitial lung disease Patient Reports February 11, 2012

side effects of Erlotinib